PubMed:32676695 / 1106-1424 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T12 23-24 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T13 35-37 http://purl.obolibrary.org/obo/CLO_0007874 denotes ms
T14 104-106 http://purl.obolibrary.org/obo/CLO_0007874 denotes ms
T15 111-117 http://purl.obolibrary.org/obo/UBERON_0003100 denotes female
T16 128-130 http://purl.obolibrary.org/obo/CLO_0007874 denotes ms
T17 135-139 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T18 135-139 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T19 240-242 http://purl.obolibrary.org/obo/CLO_0007874 denotes ms

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T35 135-139 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T13 0-318 Sentence denotes The risk of developing a QTc > 500 ms was greater in patients with prolonged baseline QTc values (≥ 440 ms for female and ≥ 460 ms for male patients) (OR 7.10 (95% IC 1.88-26.81); p = 0.004) and in patients with an increase in the QTc > 40 ms 3 days after onset of treatment (OR 30.15 (95% IC 6.96-130.55); p = 0.001).